Bixiye
P24-17 AOR No Longer Required for Submission of Organization Determinations for Platinum Blue Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: May 18, 2017
Natiijooyinka Raadinta
Soo bandhiga 2721 - 2730 ee natiijooyinka 4229
Bixiye
P11R1-17 Revised: Pre-Admission Notification Requirement for Admissions effective June 1, 2017
Taariikhda uu dhaqangalayo Barnaamijka: May 08, 2017
Bixiye
P12-16 Medicaid Claims Handling for Out of State Medicaid Members
Taariikhda uu dhaqangalayo Barnaamijka: 26, Feb 2016
Bixiye
P27R1-16 Revised: Changes to Prior Authorization Requirements for Select Services for Commercial Products
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2016
Bixiye
P19-17 American Indian Tribal Fee Schedule for Eligible Facility Services Provided to Purchased/Referred Care (PRC) -Eligible American Indians
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2017
Bixiye
P25-16 Update to Attachment B: Definition of Outpatient Health Services Categories
Taariikhda wax ku ool ah ee barnaamijka: Jun 06, 2016
Bixiye
P56-16 A New Drug, Dupilumab Will Require Prior Authorization
Taariikhda uu dhaqangalayo Barnaamijka: Nov 22, 2016
Bixiye
P4-17 Addition of Drug to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo Barnaamijka: Jan 30, 2017
Bixiye
P34-16 New Drug-Related Prior Authorization Criteria for Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channel Blocker Prior Authorization with Quantity Limit Program
Taariikhda dhaqangalka Barnaamijka: Jul 27, 2016
Bixiye
P47-16 New Drug-Related Prior Authorization Requirements for Botulinum Toxin, Remicade, Rituxan and Biologic Immunomodulators
Taariikhda uu dhaqangalayo barnaamijka: Okt 10, 2016